https://scholars.lib.ntu.edu.tw/handle/123456789/641276
Title: | Five-year Maintenance of Clinical Response and Consistent Safety Profile for Guselkumab in Asian patients with Psoriasis from VOYAGE 1 and VOYAGE 2 | Authors: | Kim, Byung Soo Jo, Seong Jin Youn, SangWoong Reich, Kristian Saadoun, Carine Chang, Chia-Ling Yang, Ya-Wen Huang, Yu-Huei TSEN-FANG TSAI |
Keywords: | Asian; Biologics; Guselkumab; Moderate-to-severe; Psoriasis | Issue Date: | Nov-2023 | Journal Volume: | 13 | Journal Issue: | 11 | Source: | Dermatology and therapy | Abstract: | Guselkumab is a human monoclonal antibody against IL-23 used in the treatment of moderate-to-severe psoriasis. This post-hoc analysis evaluated the efficacy and safety of guselkumab in the Asian subpopulation of VOYAGE 1 and VOYAGE 2 through 5 years. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/641276 | ISSN: | 2193-8210 | DOI: | 10.1007/s13555-023-01026-7 |
Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.